Why the study?
Recent data suggest roles for LIM and SH3 protein 1 (LASP1) in cell signaling and gene expression beyond its known cytoskeletal scaffolding function, especially in tumor cells.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
LASP1's expanded roles in cancer signaling may guide biomarker research; leaves open clinical validation of targeted therapies.
LIM and SH3 protein 1 was originally identified as a structural cytoskeletal protein with scaffolding function. However, recent data suggest additional roles in cell signaling and gene expression, especially in tumor cells. These novel functions are primarily regulated by the site-specific phosphorylation of LASP1. This review will focus on specific phosphorylation-dependent interaction between LASP1 and cellular proteins that orchestrate primary tumor progression and metastasis. More specifically, we will describe the role of LASP1 in chemokine receptor, and PI3K/AKT signaling. We outline the nuclear role for LASP1 in terms of epigenetics and transcriptional regulation and modulation of oncogenic mRNA translation. Finally, newly identified roles for the cytoskeletal function of LASP1 next to its known canonical F-actin binding properties are included.
No takes yet. Share an insight, caveat, or question.
Butt et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: